Pancreatic Cancer Research

ResearcherUniversité de LilleNo recent work listed

Hortense Chevalier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5219-1801; OpenAlex author ID A5027118512. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 2 papers

Papers 3

  1. FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A Multicenter Real-Life Study. Co-author DOI 10.1634/theoncologist.2020-0577↗
  2. FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study. First author DOI 10.4251/wjgo.v12.i3.332↗
  3. [Maintenance strategies for advanced pancreatic cancer: Rationale and issues]. First author DOI 10.1016/j.bulcan.2018.06.009↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anthony Turpin · 3 shared papers, 2018–2020 · strength 0.33
  2. Cindy Neuzillet · 2 shared papers, 2018–2020 · strength 0.24
  3. Déwi Vernerey · 2 shared papers, 2020 · strength 0.19
  4. Angélique Vienot · 2 shared papers, 2020 · strength 0.19
  5. Christophe Borg · 2 shared papers, 2020 · strength 0.19
  6. Charlotte Peugniez · 1 shared paper, 2020 · strength 0.10
  7. Astrid Lièvre · 1 shared paper, 2020 · strength 0.10
  8. Julien Edeline · 1 shared paper, 2020 · strength 0.10
  9. Pascal R. Hammel · 1 shared paper, 2020 · strength 0.10
  10. Christelle d’Engremont · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.